Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

Sponsor
Intellia Therapeutics
Study ID
NCT06262399
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This is a follow-up study of subjects who received NTLA-2002 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.

Key Dates

Start date
Apr 12, 2024
Status verified
Apr 2025
Primary completion
Apr 30, 2040
Completion
Apr 30, 2040

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

Incidence of treatment-related Adverse Events (AEs); incidence of treatment-related Serious Adverse Events (SAEs); incidence of treatment-related Adverse Events of Special Interest (AESIs) defined per protocol [ Time Frame: up to 15 years ]

Related Studies